De‐Chen Lin
Impact in
- Cancer Research top 0.5%
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Epigenetics and DNA Methylation 15
- RNA modifications and cancer 15
- RNA Research and Splicing 10
- Cancer-related gene regulation 10
- Ubiquitin and proteasome pathways 8
- Oncology 27
- Co-authors
- H. Phillip Koeffler (38 shared papers)Anand Mayakonda (12 shared papers)Yassen Assenov (1 shared paper)Christoph Plass (1 shared paper)Ming‐Rong Wang (15 shared papers)Dong Yin (9 shared papers)Ling‐Wen Ding (18 shared papers)Yan‐Yi Jiang (14 shared papers)
- Journals
- Cancer Research (10 papers)Nature Communications (5 papers)Blood (4 papers)Nucleic Acids Research (4 papers)Clinical Cancer Research (4 papers)
- Partner nations
- United StatesChinaSingapore
In The Last Decade
De‐Chen Lin
90 papers receiving 7.0k citations
De‐Chen Lin's Hit Papers
Peers
Comparison fields: 5 of 111
- Cancer Research 2.1k
- Oncology 1.5k
- Pulmonary and Respiratory Medicine 1.6k
- Molecular Biology 3.5k
- Immunology 614
Countries citing papers authored by De‐Chen Lin
This map shows the geographic impact of De‐Chen Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by De‐Chen Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites De‐Chen Lin more than expected).
Fields of papers citing papers by De‐Chen Lin
This network shows the impact of papers produced by De‐Chen Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by De‐Chen Lin. The network helps show where De‐Chen Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside De‐Chen Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 92 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Maftools: efficient and comprehensive analysis of somatic variants in cancer Hit paper breakdown → | 2018 | 3047 |
| 2 | Extracellular vesicle-packaged HIF-1α-stabilizing lncRNA from tumour-associated macrophages regulates aerobic glycolysis of breast cancer cells Hit paper breakdown → | 2019 | 600 |
| 3 | 2004 | 179 | |
| 4 | 2016 | 176 | |
| 5 | 2017 | 175 | |
| 6 | 2016 | 172 | |
| 7 | 2017 | 153 | |
| 8 | 2007 | 115 | |
| 9 | 2018 | 112 | |
| 10 | 2008 | 99 | |
| 11 | 2017 | 90 | |
| 12 | 2013 | 89 | |
| 13 | 2006 | 88 | |
| 14 | 2011 | 83 | |
| 15 | 2016 | 80 | |
| 16 | 2017 | 78 | |
| 17 | 2019 | 76 | |
| 18 | 2013 | 76 | |
| 19 | 2008 | 75 | |
| 20 | 2018 | 67 |
About De‐Chen Lin
De‐Chen Lin is a scholar working on Molecular Biology, Oncology, Cancer Research, Surgery and Pulmonary and Respiratory Medicine, having authored 92 papers that have together received 7.1k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (15 papers), RNA modifications and cancer (15 papers), Cancer Genomics and Diagnostics (11 papers), Esophageal Cancer Research and Treatment (11 papers), RNA Research and Splicing (10 papers), Cancer-related gene regulation (10 papers), Ubiquitin and proteasome pathways (8 papers) and Cancer-related molecular mechanisms research (8 papers). The work is most often cited by research in Cancer Research (2.1k citations), Oncology (1.5k citations), Pulmonary and Respiratory Medicine (1.6k citations), Molecular Biology (3.5k citations) and Immunology (614 citations). De‐Chen Lin has collaborated with scholars based in United States, China and Singapore. Frequent co-authors include H. Phillip Koeffler, Anand Mayakonda, Yassen Assenov, Christoph Plass, Ming‐Rong Wang, Dong Yin, Ling‐Wen Ding, Yan‐Yi Jiang, Yin Zhang and Benjamin P. Berman. Their work appears in journals such as Cancer Research, Nature Communications, Blood, Nucleic Acids Research and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.